PH25381A - 2',3'-dideoxy-2',2'-difluoronucleosides - Google Patents

2',3'-dideoxy-2',2'-difluoronucleosides

Info

Publication number
PH25381A
PH25381A PH38188A PH38188A PH25381A PH 25381 A PH25381 A PH 25381A PH 38188 A PH38188 A PH 38188A PH 38188 A PH38188 A PH 38188A PH 25381 A PH25381 A PH 25381A
Authority
PH
Philippines
Prior art keywords
difluoronucleosides
dideoxy
Prior art date
Application number
PH38188A
Other languages
English (en)
Inventor
Larry Wayne Hertel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PH25381A publication Critical patent/PH25381A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH38188A 1988-02-16 1989-02-13 2',3'-dideoxy-2',2'-difluoronucleosides PH25381A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15611688A 1988-02-16 1988-02-16

Publications (1)

Publication Number Publication Date
PH25381A true PH25381A (en) 1991-06-03

Family

ID=22558157

Family Applications (1)

Application Number Title Priority Date Filing Date
PH38188A PH25381A (en) 1988-02-16 1989-02-13 2',3'-dideoxy-2',2'-difluoronucleosides

Country Status (16)

Country Link
EP (1) EP0329348B1 (de)
JP (1) JP3142128B2 (de)
KR (1) KR890013049A (de)
CN (1) CN1035117A (de)
AU (1) AU607840B2 (de)
CA (1) CA1312599C (de)
DE (1) DE68923387T2 (de)
DK (1) DK66389A (de)
ES (1) ES2075040T3 (de)
HU (1) HU203363B (de)
IL (1) IL89258A0 (de)
MX (1) MX14910A (de)
NZ (1) NZ227960A (de)
PH (1) PH25381A (de)
PT (1) PT89705B (de)
ZA (1) ZA891076B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
FI95384C (fi) * 1989-04-06 1996-01-25 Squibb Bristol Myers Co Menetelmä 3'-deoksi-3'-substituoitujen metyylinukleosidien valmistamiseksi ja menetelmässä käytettäviä välituotteita
FI95269C (fi) * 1989-05-15 1996-01-10 Squibb Bristol Myers Co 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja
ZA907998B (en) * 1989-10-11 1991-07-31 Merrell Dow Pharma Inosine/guanosine derivatives as antineoplastic agents
JPH05501404A (ja) * 1989-11-06 1993-03-18 ニユコメド・アクシエセルカペト ヌクレオシド誘導体
AU651569B2 (en) * 1990-01-11 1994-07-28 Isis Pharmaceuticals, Inc. Compositions and methods for detecting and modulating RNA activity and gene expression
US5459255A (en) * 1990-01-11 1995-10-17 Isis Pharmaceuticals, Inc. N-2 substituted purines
CA2079796A1 (en) * 1990-04-04 1991-10-05 Jo Klaveness Nucleoside derivatives
ZA914894B (en) * 1990-07-02 1992-04-29 Squibb & Sons Inc Purinyl and pyrimidinyl tetrahydrofurans
US6262241B1 (en) 1990-08-13 2001-07-17 Isis Pharmaceuticals, Inc. Compound for detecting and modulating RNA activity and gene expression
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
AU4134793A (en) * 1992-06-22 1993-12-23 Eli Lilly And Company 2'-deoxy-2',2'-difluoro(2,6,8-substituted) purine nucleosides having anti-viral and anti-cancer activity and intermediates
US6013790A (en) * 1996-09-25 2000-01-11 Board Of Regents University Of Nebraska-Lincoln Heavily fluorinated sugar analogs
GB2321454A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Gemcitabine esters and amides
US6326507B1 (en) 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
US7435755B2 (en) 2000-11-28 2008-10-14 The Trustees Of Dartmouth College CDDO-compounds and combination therapies thereof
WO2003059339A1 (en) 2002-01-15 2003-07-24 Trustees Of Dartmouth College Tricyclic-bis-enone derivatives and methods of use thereof
US7265096B2 (en) 2002-11-04 2007-09-04 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
US8921340B2 (en) 2006-11-17 2014-12-30 Trustees Of Dartmouth College Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
WO2008064133A1 (en) 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthesis and biological activities of new tricyclic-bis-enones (tbes)
US8299046B2 (en) 2006-11-17 2012-10-30 Trustees Of Dartmouth College Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
EP2217247A4 (de) 2007-11-06 2011-12-28 Pharmaessentia Corp Neue synthese von beta-nucleosiden
WO2009089545A1 (en) 2008-01-11 2009-07-16 Reata Pharmaceuticals, Inc. Synthetic triterpenoids and methods of use in the treatment of disease
CN102164941B (zh) 2008-04-18 2015-05-27 里亚塔医药公司 抗氧化剂炎症调节剂:具有饱和c环的齐墩果酸衍生物
WO2009146216A2 (en) 2008-04-18 2009-12-03 Reata Pharmaceuticals. Inc. Antioxidant inflammation modulators: novel derivatives of oleanolic acid
CA2721838C (en) 2008-04-18 2017-05-23 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
BRPI0911422B8 (pt) 2008-04-18 2021-05-25 Reata Pharmaceuticals Inc compostos moduladores inflamatórios antioxidantes, composição farmacêutica e usos dos mesmos
MX2010011435A (es) 2008-04-18 2011-01-25 Reata Pharmaceuticals Inc Compuestos que incluyen un nucleo farmaceutico antiinflamatorio y sus metodos de uso.
DK2833905T3 (en) 2012-04-04 2018-07-30 Halozyme Inc Combination therapy with hyaluronidase and a tumor-targeted taxane
US8921419B2 (en) 2012-05-08 2014-12-30 Trustees Of Dartmouth College Triterpenoids and compositions containing the same
WO2019222435A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
ATE92499T1 (de) * 1984-12-04 1993-08-15 Lilly Co Eli Tumorbehandlung bei saeugetieren.
RU1787160C (ru) * 1986-12-24 1993-01-07 Эли Лилли Энд Компани Способ получени иммуноглобулинового конъюгата

Also Published As

Publication number Publication date
JP3142128B2 (ja) 2001-03-07
DE68923387T2 (de) 1996-01-25
PT89705A (pt) 1989-10-04
IL89258A0 (en) 1989-09-10
KR890013049A (ko) 1989-09-21
NZ227960A (en) 1990-11-27
DK66389A (da) 1989-08-17
PT89705B (pt) 1994-04-29
AU2992689A (en) 1989-08-17
CN1035117A (zh) 1989-08-30
MX14910A (es) 1993-11-01
EP0329348A2 (de) 1989-08-23
HU203363B (en) 1991-07-29
ZA891076B (en) 1990-10-31
CA1312599C (en) 1993-01-12
EP0329348B1 (de) 1995-07-12
DK66389D0 (da) 1989-02-13
DE68923387D1 (de) 1995-08-17
JPH01249797A (ja) 1989-10-05
HUT49366A (en) 1989-09-28
AU607840B2 (en) 1991-03-14
EP0329348A3 (en) 1990-09-12
ES2075040T3 (es) 1995-10-01

Similar Documents

Publication Publication Date Title
PH25381A (en) 2',3'-dideoxy-2',2'-difluoronucleosides
EG18875A (en) Alpha-aryl-alpha-phenylethyl-1h-1,2,4-triazole-1-propanenitriles
AR244666A1 (es) Procedimiento para preparar compuestos piperidinilicos 1,4-disustituidos, utiles como analgesicos y relajantes musculares.
PH25045A (en) 1,2,3,6-tetrahydro-5-nitro-pyrimidine derivatives
ZA8784B (en) 1,6-anhydro-beta-hexopyranose derivatives
ZA874093B (en) Certain 2-phenylacetyl-1,3,5-cyclohexanetriones
ZA895454B (en) 2,2-dihalogenocy-clopropyl-hydroxy-ethyltriazoles
CS932686A1 (en) Zpusob pripravy 2,6 diaminomesitylen 4 sulfonove kyseliny
IE890468L (en) 2', 3' - dideoxy-2',2'-difluoronucleosides
ZA891059B (en) 1-aminomethyl-3-(2,4-difluoro-3-chlorophenyl)-4-cyano-pyrroles
IE880816L (en) 2',3'-dideoxynucleosides
CS393386A1 (en) Sposob pripravy 2,2 dibenztiazolyldisulfidu
CS650086A1 (en) Zpusob pripravy 2,6 dichlordifenylaminu
CS267188A1 (en) 1,2,2,6,6-pentamethyl-4-allyloxypiperidine
IE881104L (en) 2,3-bicyclopyrazolidinones
IE882166L (en) 11ß-PHENYL-4,9,15-ESTRATRIENES
IE881897L (en) 2, 2-dimethylchroman-3-ols
IE883873L (en) 1-aralkyl-1,2,-dihydropyrimidine-2-thiones
ZA899367B (en) 4,5,6,7-tetrahydrobenzimidazole derivatives
ZA89387B (en) 1,4-disubstituted-piperidinyl compounds
IE890176L (en) 1,4-disubstituted-piperidinyl compounds
ZA893348B (en) Prodrugs of 2',3'-dideoxy-2',3'-didehydronucleosides
IE883874L (en) 4-aralkyl-5-substituted-1,2,4-triazoles
GB8807523D0 (en) 1,2,4-trioxanes related to arteannuin
IE881100L (en) 1,3-Dioxanes